Proteomics

Dataset Information

Targeted delivery of itaconic acid by butyrate modified liposomes improves primary biliary cholangitis by regulating Th17/Treg cell balance through epigenetic reprogramming


ABSTRACT: Primary biliary cholangitis (PBC) is a chronic autoimmune disease. The aim of this study is to design a liposome nanoparticle modified with butyrate (Bu) loaded with Itaconic acid (IA)( LNP-Bu@IA )Targeted delivery of IA and regulation of Th17/Treg cell balance through metabolic and epigenetic reprogramming to improve primary biliary cholangitis, providing a new strategy for the treatment of PBC.

ORGANISM(S): Mus Musculus

SUBMITTER: Long Qian  

PROVIDER: PXD070328 | iProX | Tue Nov 04 00:00:00 GMT 2025

REPOSITORIES: iProX